The American Diabetes Trial Landscape
The United States runs more diabetes research studies than any other country, with active trials spread across academic medical centers, community clinics, and even pharmacy chains. From the Omnipod automated insulin delivery algorithm being tested in adults with type 2 diabetes to the REMIT2D study looking at whether continuous glucose monitoring can help push people into remission, the research pipeline is crowded with options.
What makes the US landscape distinct is its geographic reach. A weight loss and glucose monitoring study at Stanford pays participants between $50 and $75 per visit, while a cagrilintide trial for adults with overweight and type 2 diabetes recruits across 67 locations from Birmingham, Alabama to Las Vegas, Nevada. For someone living in rural Texas or the Midwest, the practical question is rarely whether trials exist, but how to find one within reasonable travel distance.
Three cultural realities shape how Americans approach these studies. First, distance and transportation often decide participation more than medical interest does. Second, Americans increasingly expect transparency about costs, compensation, and what happens if something goes wrong. Third, there is healthy skepticism, especially among communities that have historically been under-represented in research, which is why many studies now make a deliberate effort to recruit underserved and high-need groups.
What Trials Currently Target
Most active diabetes management trials in the US fall into four buckets. Medication studies test next-generation GLP-1 receptor agonists and combinations like cagrilintide or oral semaglutide. Device trials evaluate automated insulin delivery systems and continuous glucose monitors, such as the FreeStyle Libre 3 study for adults with type 2 diabetes on basal insulin. Lifestyle and digital intervention studies, including the AI-powered prevention program validated in a large randomized trial, compare apps with human coaching. And a growing number of studies focus on remission itself, testing whether low-calorie meal replacement combined with glucose monitoring can bring HbA1c below the diabetes threshold.
The direction has shifted noticeably. Researchers no longer measure success only by HbA1c reduction. The STRIVE trial, for example, reported a 5.7 percent increase in time spent in the tight glucose range of 70 to 140 mg/dL, with no severe hypoglycemia events. Studies are now chasing time in range, cardiovascular outcomes, and remission rates as the real markers of progress.
A Practical Comparison of Trial Types
| Trial Type | Common Example | Typical Cost to Participant | Best Fit For | Advantages | Challenges |
|---|
| Medication trials | Cagrilintide, oral GLP-1 studies | Study covers drug and related tests | People stable on current meds | Access to newer therapy | Possible placebo assignment |
| Device trials | Omnipod 6, FreeStyle Libre 3 | Device and supplies provided | Those using or open to pumps/CGM | Real-time glucose insight | Time commitment for training |
| Lifestyle and digital trials | AI prevention app, Weight Watchers CGM | Program access provided | Prediabetes or early type 2 | Behavioral support built in | Requires consistent engagement |
| Remission-focused trials | REMIT2D meal replacement study | Study pays for program | Motivated to reverse diabetes | Potential for meaningful change | Strict diet adherence needed |
Compensation varies widely. Some studies offer modest travel reimbursement, others pay per visit, and a few offer no payment at all beyond study-related care. Policies are always explained during the informed consent process, so there are no surprises about what you will and will not receive.
How to Find the Right Study
Start with the people who already know your health history. Your primary care doctor or endocrinologist can often point you to nearby research groups, and many clinics maintain direct relationships with trial sites. The American Diabetes Association runs a clinical trials resource page that explains the basics and connects you with current opportunities. ClinicalTrials.gov remains the most comprehensive national database, letting you filter by condition, state, and whether a study is actively recruiting.
When you identify a promising study, ask targeted questions before enrolling. Confirm whether study-related tests and medications are covered, whether there is compensation for time and travel, how many visits are required, and whether you can withdraw at any time without penalty. Every legitimate US trial requires informed consent, which means you must understand the risks and benefits before signing anything.
For veterans of diabetes care, the real value often comes from the close monitoring. Regular check-ins, detailed lab panels, and access to research coordinators who know your case can be worth more than the compensation alone. Sarah, a participant in a Midwest device study, put it simply: the twice-weekly check-ins taught her more about her glucose patterns than years of standard appointments had.
The landscape keeps moving. Trials that once required daily visits now offer remote monitoring, and researchers are working hard to include people from rural areas and underserved communities. If you have been managing diabetes for years and feel stuck, a clinical trial might offer the kind of structured attention that routine care rarely provides. Start the conversation with your care team, ask the right questions, and let the informed consent process guide your decision.
研究の知恵